Docebo Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DCBO research report →
Range $25 – $38
Price Chart
About the company
Docebo Inc. develops and provides learning management platform for training in Canada, the United States, and internationally. The company’s cloud platform consists of a learning suite, which includes Docebo Learn platform, a cloud-based learning platform that allows learning administrators to deliver personalized learning; Docebo Content Marketplace, an access to off-the-shelf learning content and provide predeveloped learning content; Insights module allows organizations to understand the results of learning programs with data visualizations; Learning Evaluation module to incorporate the learner’s perspective into analyses by collection of feedback; and Advanced Analytics Pack to integrate learning data into data ecosystem and BI tool.
- CEO
- Alessio Artuffo
- IPO
- 2020
- Employees
- 966
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on DCBO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $694.04M
- P/E
- 22.10
- Fwd P/E
- 15.69
- PEG
- 0.28
- P/S
- 2.81
- P/B
- -132.41
- EV/EBITDA
- 27.62
- Div Yield
- 8.03%
- Gross Margin
- 79.16%
- Op Margin
- 9.57%
- Net Margin
- 13.79%
- ROE
- 219.25%
- ROIC
- 27.46%
Latest fiscal year · YoY change
- Revenue
- $242.69M+11.9%
- Gross Profit
- $194.84M+10.9%
- Op Income
- $24.48M
- Net Income
- $37.51M+40.3%
- EPS
- $1.33+51.1%
- OCF Growth
- +2.9%
- FCF Growth
- +3.9%
- 52W High
- $33.19
- 52W Low
- $14.39
- 50D MA
- $27.20
- 200D MA
- $21.25
- Beta
- 0.81
- RSI (14)
- 43
- Avg Volume
- 53.05K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Docebo said Q3 was another strong quarter, with continued enterprise momentum, early traction in new verticals and AI-driven products, and a more shareholder-friendly capital allocation stance highlighted by a special dividend.· November 6, 2026
- Government vertical traction was stronger than expected, with a robust pipeline and management expecting several significant deals to close in the fiscal year.
- Healthcare is becoming a bigger focus, with management saying more wins should follow as it builds domain expertise, hires specialists and sharpens the product roadmap.
- The new Knowledge offering is expanding Docebo’s reach beyond traditional L&D buyers toward CIO, CRO and CCO stakeholders, aided by AI and access to broader enterprise data.
- Management announced an approximately $60 million one-time special dividend and said capital allocation priorities remain: reinvest in the business, do selective M&A, and return excess cash to shareholders.
- Gross margin pressure is tied mainly to professional services mix, while management still expects strong EBITDA margins and some margin expansion longer term.
Docebo did not state consolidated revenue or EPS figures in the transcript, but management said Q3 subscription revenue grew 12.4% year over year and full-year 2026 revenue growth is now projected to be 14%+ versus the 10.6% midpoint initially guided in February. Brandon Farber said the company is guiding to Q4 subscription revenue growth of 12.8%, with Q4 guidance built off Q3 run-rate, October FX pressure and heavy enterprise deals that tend to close late. On profitability, he said the company is still projecting 20%+ EBITDA margins, net debt is $108 million after the planned special dividend, debt capacity increases from $90 million to $150 million, and net debt to EBITDA is 1.9x using projected adjusted EBITDA of $56 million. He also said the company repurchased $82 million of stock in 2026, buying back 4.1 million shares at an average price of $19.97.
Alessio Artuffo struck a confident, upbeat tone and emphasized execution across multiple growth vectors. He said government is already exceeding initial expectations, healthcare should see more wins, and Knowledge/AI is broadening Docebo’s value proposition from training into broader enterprise knowledge workflows. He repeatedly framed the company as early in these initiatives, but said the product, go-to-market and vertical specialization are being built intentionally for 2027 and beyond.
Brandon Farber focused on capital allocation, margin structure and the mechanics behind guidance. He said the special dividend will be funded from remaining debt capacity, moving debt from $90 million to $150 million and leaving the company at 1.9x net debt to projected adjusted EBITDA. He reiterated that the company will keep investing in healthcare, FTE and government while still targeting 20%+ EBITDA margins, noted $82 million of 2026 buybacks, and said professional services mix is pressuring gross margin even though subscription gross margin remains unchanged historically. He also said he expects some EBITDA margin expansion into 2027 and beyond, with R&D roughly flat as a percentage of revenue and G&A continuing to leverage.
Analysts pressed on government pipeline timing, the rationale for the special dividend, guidance conservatism, healthcare investment, gross margin pressure and whether the new Knowledge/AI products could lengthen sales cycles or expand the buyer set. Management said the government pipeline is strong but procurement is often slow and lumpy, so some large deals slipped from Q3 into the fiscal year. On guidance, Farber said Q4 is constructed conservatively from the Q3 base, FX and deal timing, and that the higher enterprise mix and late-closing deals largely affect 2027 guidance rather than Q4. On product, management said the CIO is already involved in sales cycles, but Knowledge and agents should make the CIO even more relevant and could lift ticket sizes from historical $100k-$200k to larger multi-product deals.
The call showed multiple sources of upside: a stronger-than-expected government pipeline, healthcare expansion, and early customer enthusiasm for Knowledge, agents and skills intelligence. Management also said subscription revenue growth has rebounded consistently through the year and that the new product set can raise deal sizes and broaden the buyer base.
Near-term execution still depends on converting a maturing government pipeline and navigating slow procurement processes, which can push deals between quarters. Gross margin is under pressure from faster-growing professional services, and management is still developing the commercial thesis for AI/Knowledge monetization, including pricing and sales-cycle impacts, so some of the upside is still early-stage.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 35.2%
- Shares Outstanding
- 24.95M
- Float Shares
- 8.78M
of shares held by institutions
60 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Beutel, Goodman & Co Ltd. | 1.51M | ▼ 40.84K |
| Topline Capital Management, LLC | 664.73K | ▼ 214.18K |
| Arrowstreet Capital, Limited Partnership | 619.09K | ▼ 3.21K |
| Quadrature Capital Ltd | 234.90K | ▼ 61.31K |
| Two Sigma Investments, LP | 196.19K | ▼ 77.74K |
| Acadian Asset Management LLC | 194.87K | ▲ 114.11K |
| Sparta 24 Ltd. | 162.64K | ▼ 37.13K |
| Renaissance Technologies LLC | 136.73K | ▲ 28.90K |
| Barclays PLC | 101.62K | ▲ 100.12K |
| Tocqueville Asset Management L.P. | 80.00K | ▲ 80.00K |
| Goldman Sachs Group Inc | 77.21K | ▼ 2.24K |
| Claret Asset Management Corp | 62.43K | ▲ 27.32K |
Held by 1 ETFs
Biggest fund positions in DCBO by dollar value.
Our DCBO coverage
Recent articles, reports, and earnings notes.
No research on DCBO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DCBO report →Docebo Announces Participation in Upcoming Investor Conferences in November
businesswire.com · Nov 12
Are Computer and Technology Stocks Lagging Docebo (DCBO) This Year?
zacks.com · Nov 11
Docebo Inc. (DCBO) Crossed Above the 20-Day Moving Average: What That Means for Investors
zacks.com · Nov 10
Amplitude (NASDAQ:AMPL) and Docebo (NASDAQ:DCBO) Critical Contrast
defenseworld.net · Nov 8
Docebo Inc. (DCBO:CA) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 6
Docebo Q3 Earnings Call Highlights
marketbeat.com · Nov 6
Docebo Inc. (DCBO) Q3 Earnings and Revenues Surpass Estimates
zacks.com · Nov 6
Docebo Inc. Announces US$60 Million Special Dividend
businesswire.com · Nov 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.